经乳头胆囊支架置入用于急性胆囊炎长期治疗
本研究评估经内镜逆行胰胆管造影引导下经乳头胆囊引流(ERGD)并置入双猪尾塑料支架,作为不适合胆囊切除术的急性胆囊炎患者的长期治疗。长期成功率95.9%(47/49),技术成功率96%(49/51),技术成功者临床成功率100%,轻度不良事件5.9%(n=3)。
要点
- ERGD双猪尾支架置入对不适合手术的急性胆囊炎患者长期安全有效。
- 单支架置入与更多重复操作相关,双支架置入可能延长复发时间。
- 支架移除和单支架治疗是复发的风险因素。
核心结论
- 经乳头胆囊双猪尾塑料支架置入的ERGD是不适合手术的急性胆囊炎患者安全有效的长期治疗。
- 复发风险因素包括支架移除和单支架治疗,双支架治疗可能为优选方式。
研究设计与样本
- 长期成功定义为ERGD后至6个月、死亡或再干预前无急性胆囊炎复发。
主要发现
- 长期成功率为95.9%(47/49),技术成功率为96%(49/51),技术成功者临床成功率为100%。
- 轻度不良事件发生率为5.9%(n=3),平均随访453天(范围18-1879天)。
关键数值与推荐
- 技术成功定义为至少1枚经乳头支架置入胆囊,临床成功定义为急性胆囊炎症状缓解并出院。
- 长期成功定义为ERGD后至6个月、死亡或再干预前无急性胆囊炎复发。
临床怎么用
- 对于不适合胆囊切除术的急性胆囊炎患者,可考虑ERGD并置入双猪尾塑料支架作为长期治疗。
- 双支架置入在技术上并非总能实现,但可能挽救单支架治疗失败或择期支架移除后复发的情况。
局限性
- 单中心回顾性研究,样本量较小(49例长期成功评估)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Select patients with acute cholecystitis (AC) are poor candidates for cholecystectomy. ERCP-guided transpapillary gallbladder (GB) drainage (ERGD) is one modality for nonoperative management of AC in these patients. Our primary aim was to evaluate long-term success of destination ERGD. Secondary aims were the rate of technical and clinical success, number of repeat procedures, rate of adverse events, and risk factors for recurrent AC. METHODS: Consecutive patients with AC who were not candidates for cholecystectomy underwent ERGD with attempted transpapillary GB plastic double-pigtail stent placement at a tertiary hospital from January 2008 to December 2019. Long-term success was defined as no AC after ERGD until 6 months, death, or reintervention. Technical success was defined as placement of at least 1 transpapillary stent into the GB and clinical success as resolution of AC symptoms with discharge from the hospital. RESULTS: Long-term success was achieved in 95.9% of patients (47/49), technical success in 96% (49/51), and clinical success 100% in those with technical success. Mild adverse events occurred in 5.9% (n = 3). Mean follow-up was 453 days after ERGD (range, 18-1879). A trend toward longer time to recurrence of AC was seen in patients with 2 rather than 1 GB stent placed (P = .13), and more repeat procedures were performed when a single stent was placed (P = .045). CONCLUSIONS: ERGD with transpapillary GB double-pigtail stent placement is a safe and effective long-term therapy for poor surgical candidates with AC. Risk factors for recurrence include stent removal and single-stent therapy. Double-stent therapy is not always technically feasible but may salvage failed single-stent therapy or recurrence after elective stent removal and may therefore be the preferred treatment modality.
引用
- Storm AC, Vargas EJ, Chin JY, et al. Transpapillary gallbladder stent placement for long-term therapy of acute cholecystitis. Gastrointest Endosc. 2021. PMID: 33798540. doi:10.1016/j.gie.2021.03.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。